Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combining Ultrasound and Biochemistry in First-Trimester Screening for Down's syndrome

1 Sept 1997

Abstract excerpt

Data on pregnancies with and without Down's syndrome between 10 and 14 weeks of pregnancy were used to determine the performance of combined ultrasound and biochemical markers in prenatal screening for Down's syndrome. We used three datasets: one published by Pandya et al. (1995) on nuchal translucency measurement in 86 Down's syndrome pregnancies; one published by Wald et al. (1996a) on free beta human chorionic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Anomalies and Fetal Surgery
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9316126
DOI: 10.1002/(sici)1097-0223(199709)17:9<821::aid-pd154>3.0.co;2-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combining Ultrasound and Biochemistry in First-Trimester Screening for Down's syndromePMID 9316126Read ↗

First‐trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practiceSemantic proximity Read ↗

First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucencySemantic proximity Read ↗

First trimester fetal nuchal translucencySemantic proximity Read ↗

First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucencySemantic proximity Read ↗

Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnanciesSemantic proximity Read ↗

First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screeningSemantic proximity Read ↗

First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screeningSemantic proximity Read ↗

The history of the second‐trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practiceSemantic proximity Read ↗

Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐ASemantic proximity Read ↗

First-Trimester Combined Screening for Down Syndrome and Other Fetal AnomaliesSemantic proximity Read ↗

First and Second Trimester Antenatal Screening for Down's Syndrome: The Results of the Serum, Urine and Ultrasound Screening Study (SURUSS)Semantic proximity Read ↗

Nuchal translucency and first trimester biochemical markers for down syndrome screening: A cost-effectiveness analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.